Nakai T, Oida K
3rd Department of Internal Medicine, Fukui Medical School.
Rinsho Byori. 1990 Feb;38(2):125-34.
The apolipoproteins are important determinants of the structure and metabolism of plasma lipoproteins. This paper reviews analytical methods and the clinical significance of plasma apolipoproteins. Our data on apo VLDL and apo HDL analysis using fast protein liquid chromatography (FPLC), monoclonal antibody against apo VLDL, especially apo C-I, apo B isoproteins (apo B-100 and apo B-48) and plasma apolipoprotein concentrations in the patients with diabetes mellitus and coronary heart disease, were described. Among the methods of apolipoprotein quantification, single radial immunodiffusion (SRID) is widely used in Japan and plasma concentrations of apo A-I, A-II, B, C-II, C-III and E in healthy adults were reported. We showed the usefulness of FPLC for fractionation of human apo VLDL and apo HDL. We prepared several monoclonal antibodies against human apo VLDL, especially apo C-I, which were used for quantification and structural analysis of plasma apo C-I. Apo B-48 was found to be a good metabolic marker of exogenous lipoproteins (chylomicron and chylomicron remnant) and apo B-48 containing lipoproteins were increased in the poorly controlled diabetic patients.
载脂蛋白是血浆脂蛋白结构和代谢的重要决定因素。本文综述了血浆载脂蛋白的分析方法及其临床意义。描述了我们使用快速蛋白质液相色谱法(FPLC)分析载脂蛋白VLDL和载脂蛋白HDL、抗载脂蛋白VLDL单克隆抗体(尤其是载脂蛋白C-I)、载脂蛋白B同工型(载脂蛋白B-100和载脂蛋白B-48)以及糖尿病和冠心病患者血浆载脂蛋白浓度的数据。在载脂蛋白定量方法中,单向免疫扩散法(SRID)在日本被广泛使用,并且报道了健康成年人血浆中载脂蛋白A-I、A-II、B、C-II、C-III和E的浓度。我们展示了FPLC用于分离人载脂蛋白VLDL和载脂蛋白HDL的有效性。我们制备了几种抗人载脂蛋白VLDL单克隆抗体,尤其是抗载脂蛋白C-I单克隆抗体,用于血浆载脂蛋白C-I的定量和结构分析。发现载脂蛋白B-48是外源性脂蛋白(乳糜微粒和乳糜微粒残粒)的良好代谢标志物,并且在血糖控制不佳的糖尿病患者中,含载脂蛋白B-48的脂蛋白增加。